Mounjaro® Pen
Dual-action GLP-1 and GIP injection
Lose an average of 22.5% of body weight over 72 weeks*
Start Free Assessment
From £179.99 per pen
*SURMOUNT-1, a 72-week clinical trial of adults with obesity using the highest dose of Mounjaro (tirzepatide 15mg) alongside lifestyle changes. Individual results vary.
Overview
- Mimics two gut hormones (GLP-1 and GIP) that regulate appetite and fullness
- One pen delivers 4 weekly doses
- Dose is increased gradually under pharmacist review
How to take it
One self-administered injection per week, any day, with or without food.
Once weekly, self-injected. Your dose is only ever increased with pharmacist sign-off, based on how you're tolerating your current dose.